J. Martinou

Molecular Biology · 2000–2018

A researcher in the Science corpus: 13 papers; trusts 7 researchers and is trusted by 21 researchers here, as inferred from the citation graph.

Subfields

Whom J. Martinou trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Desagher
  2. J. Nunnari
  3. J. Chipuk
  4. Douglas R. Green
  5. G. Salvesen
  6. B. Westermann
  7. Guido Kroemer
  8. R. Youle
  9. T. Kuwana
  10. M. Karbowski

Who trusts J. Martinou overall

  1. D. C. Chan
  2. Jerry M. Adams
  3. A. Halestrap
  4. R. Youle
  5. M. Fricker
  6. J. Nunnari
  7. Aida Peña‐Blanco
  8. M. Karbowski
  9. Douglas R. Green
  10. Wen Chen

Papers from J. Martinou's perspective

Ordered by how strongly the researchers J. Martinou trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Role of Bax and Bak in mitochondrial morphogenesis (Nature)
  2. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. (Cell)
  3. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. (Cell)
  4. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. (Molecules and Cells)
  5. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy (EMBO Journal)
  6. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. (Developmental Cell)
  7. Mitochondria and cell death: outer membrane permeabilization and beyond (Nature reviews. Molecular cell biology)
  8. hFis1, a Novel Component of the Mammalian Mitochondrial Fission Machinery* (Journal of Biological Chemistry)
  9. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. (Developmental Cell)
  10. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. (Cancer Cell)

Their papers